Dr James Williams has broad experience covering executive and non-executive management of public and private companies; establishment, resourcing and financing of start-up companies; and hands-on research in molecular and cell biology.
As a co-founder and Investment Director of Yuuwa Capital LP, a $40 million VC fund set up under the Australian Government’s Innovation Investment Fund program, Dr Williams has an active involvement in all investment related activities. Yuuwa is not currently making new investments and is focused on growing its portfolio companies towards exits. Additional active portfolio companies include: iCetana Ltd (ASX:ICE), AgWorld Pty Ltd, Nexgen Plants Pty Ltd and Fitgenes Ltd.
Dr Williams has been CEO of private and listed medical device companies Argus Biomedical Pty Ltd and Resonance Health Ltd (spin-out companies from the Lions Eye Institute and UWA respectively), and in both, oversaw regulatory approvals and market launch of first products. He conceived the technology behind drug delivery company iCeutica and held various executive and non-executive roles through until its sale. To date, three drugs have been approved by the FDA on the basis of the iCeutica technology. He is the former CEO, and remains Chairman of ASX-listed Dimerix Limited, an ASX-listed drug discovery company with Phase 2 clinical trials in chronic kidney disease.
He is a former Director of Linear Clinical Research Ltd, an early stage clinical trials unit based in Perth. He has also been a Director and Interim-CEO of a boutique distillery.
Prior to becoming involved in technology commercialisation, Dr Williams was Senior Research Officer at the Western Australian Institute for Medical Research where he researched the molecular and cellular biology of cancer. He has numerous publications in leading international journals and is named as inventor on patents covering a range of disciplines that are being prosecuted as part of Australian and US companies’ technology portfolios.
Dr Williams completed his Honours Degree in Biochemistry at Aberdeen University, Doctorate in Medicine at the University of Melbourne, and Masters of Business Administration at the University of Western Australia.
- Co-founder and Investment Director of Yuuwa Capital LP.
- Director of Yuuwa investee company PolyActiva Pty Ltd and Alternate Director of AdAlta Limited (ASX:1AD).
- Chairman of Dimerix Limited (ASX:DXB).
- Member of ISA Entrepreneurs Program Committee.
- Member of UWA Pathfinder Advisory Panel.